| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 192 |
| 1 | NIVOLUMAB | 165 |
| 2 | PREDNISONE | 163 |
| 3 | HYDROCORTISONE | 127 |
| 4 | LEVOTHYROXINE SODIUM | 105 |
| 5 | IPILIMUMAB | 98 |
| 6 | ERGOCALCIFEROL | 96 |
| 7 | HYDROCORTISONE ACETATE | 82 |
| 8 | HYDROCORTISONE CREAM | 82 |
| 9 | ANTI ITCH | 80 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GABA (GAMMA-AMINOBUTYRIC ACID) | 1 | 0.0047 |
| 1 | .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN D | 1 | 0.0045 |
| 2 | DEMECLOCYCLINE | 1 | 0.0044 |
| 3 | ERGOCALCIFEROL | 96 | 0.0032 |
| 4 | TREMELIMUMAB | 14 | 0.0032 |
| 5 | AVELUMAB | 12 | 0.0029 |
| 6 | BORIC ACID | 1 | 0.0028 |
| 7 | ESTRADIOL ACETATE | 2 | 0.0026 |
| 8 | CORTISOL | 1 | 0.0025 |
| 9 | IPILIMUMAB | 98 | 0.0022 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 391 |
| 1 | Corticosteroid [EPC] | 378 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 164 |
| 3 | Benzodiazepine [EPC] | 127 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 108 |
| 5 | Provitamin D2 Compound [EPC] | 96 |
| 6 | Vitamin C [EPC] | 89 |
| 7 | Platinum-based Drug [EPC] | 87 |
| 8 | Proton Pump Inhibitor [EPC] | 80 |
| 9 | Kinase Inhibitor [EPC] | 79 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 391 | 0.0040 |
| 2 | Provitamin D2 Compound [EPC] | 96 | 0.0032 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 4 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 108 | 0.0022 |
| 6 | Adrenal Steroid Synthesis Inhibitor [EPC] | 2 | 0.0020 |
| 7 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 41 | 0.0019 |
| 9 | Progestin Antagonist [EPC] | 9 | 0.0019 |